TET2 Overexpression in Chronic Lymphocytic Leukemia Is Unrelated to the Presence of TET2 Variations

TET2 is involved in a variety of hematopoietic malignancies, mainly in myeloid malignancies. Most mutations of TET2 have been identified in myeloid disorders, but some have also recently been described in mature lymphoid neoplasms. In contrast to the large amount of data about mutations of TET2, som...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernández-Sánchez, María, Rodríguez, Ana Eugenia, Kohlmann, Alexander, Benito, Rocío, García, Juan Luis, Risueño, Alberto, Fermiñán, Encarna, De Las Rivas, Javier, González, Marcos, Hernández-Rivas, Jesús-María
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3947698/
https://www.ncbi.nlm.nih.gov/pubmed/24693539
http://dx.doi.org/10.1155/2014/814294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3947698/
https://www.ncbi.nlm.nih.gov/pubmed/24693539
http://dx.doi.org/10.1155/2014/814294

Ejemplares similares